Lipid profile in young people with newly diagnosed type 2 diabetes mellitus
https://doi.org/10.15372/ATER20180306
Abstract
Diabetes mellitus (DM) is one of the most important not only medical but also social problems. With the development of vascular complications in people with diabetes in all age groups associated with the presence of dyslipidemia which is why these patients need to determine the lipid spectrum. In 30 patients aged 45 years with newly diagnosed type 2 diabetes (DM2) and in a control group comparable in sex, age and body mass index (BMI), the lipid profile was studied. Statistically significant differences were not detected not by one indicator between persons with hyperglycemia and with normoglycemia but the average levels of total cholesterol and low-density lipoprotein cholesterol were higher than the target values in both groups. There are no gender differences either. Perhaps this is due to a small amount of DM at which metabolic changes have not yet developed.
About the Authors
A. K. Ovsyannikova
Institute of Internal and Preventive medicine - Branch of Federal Research Institute of Cytology and Genetics of SB RAS
Russian Federation
Russian Federation
L. V. Shcherbakova
Institute of Internal and Preventive medicine - Branch of Federal Research Institute of Cytology and Genetics of SB RAS
Russian Federation
Russian Federation
S. V. Mustafina
Institute of Internal and Preventive medicine - Branch of Federal Research Institute of Cytology and Genetics of SB RAS
Russian Federation
Russian Federation
Yu. I. Ragino
Institute of Internal and Preventive medicine - Branch of Federal Research Institute of Cytology and Genetics of SB RAS
Russian Federation
Russian Federation
D. V. Denisova
Institute of Internal and Preventive medicine - Branch of Federal Research Institute of Cytology and Genetics of SB RAS
Russian Federation
Russian Federation
A. K. Kuntsevich
Institute of Internal and Preventive medicine - Branch of Federal Research Institute of Cytology and Genetics of SB RAS
Russian Federation
Russian Federation
O. D. Rymar
Institute of Internal and Preventive medicine - Branch of Federal Research Institute of Cytology and Genetics of SB RAS
Russian Federation
Russian Federation
References
1. Li X., Deng Y.P., Yang M. et al. Triglyceride to high-density lipoprotein cholesterol ratio and carotid intima-medial thickness in Chinese adolescents with newly diagnosed type 2 diabetes mellitus // Pediatr. Diabetes. 2016. Vol. 17, N 2. P. 87-92.
2. Gong Y., Che T.T., Liu S.F., Ren Y. Characteristics of newly diagnosed diabetes patients with young onset in the West China Hospital of Sichuan University // J. Sichuan University. Med. Sci. Ed. 2014. Vol. 45, N 3. P. 524-528.
3. Аронов Д.М., Арабидзе Г.Г., Ахмеджанов Н.М. и др. Диагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеросклероза. Российские рекомендации. VI пересмотр. М., 2017. С. 44.
4. Рекомендации экспертов всероссийского научного общества кардиологов по диагностике и лечению метаболического синдрома. Второй пересмотр // Практ. медицина. 2010. Т. 5, № 44. С. 81-101.
5. Молекулярная генетика и клиника MODY диабета. Новосибирск: Изд-во СО РАН, 2016. С. 156.
6. Ahlqvist E., Ahluwalia T.S., Groop L. Genetics of type 2 diabetes // Clin. Chem. 2011. Vol. 57. P. 241-254.
7. Shield J.P. et al. Management and 1 year outcome for UK children with type 2 diabetes // Arch. Dis. Child. 2009. Vol. 94. P. 206-209.
8. Bianco A. et al. The relationship between type 2 diabetes family history, body composition and blood basalglycemia in sedentary people // Acta Diabetol. 2014. Vol. 51. P. 79-84.
9. Мустафина С.В., Рымар О.Д., Малютина С.К. и др. Распространенность сахарного диабета у взрослого населения Новосибирска // Сахар. диабет. 2017. Т. 20, № 5. С. 329-334.
10. Garber A.J., Handelsman Y., Einhorn D. et al. Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists // Endocr. Pract. 2008. Vol. 14. P. 933-946.
11. Nathan D.M., Zinman B. et al. Modern-day clinical course of type 1 diabetes mellitus after 30 years’ duration: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications and Pittsburgh Epidemiology of Diabetes Complications Experience (1983-2005) // Arch. Intern. Med. 2009. Vol. 169. P. 1307-1316.
12. Handelsman Y., Bloomgarden Z.T., Grunberger G. et al. American Association of Clinical Endocrinologists and American College of Endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015 // Endocr. Pract. 2015. Vol. 21, Suppl. 1. P. 1-87.
13. Аметов А.С., Сокарева Е.В. Нарушения липидного обмена при сахарном диабете 2-го типа и их коррекция // Рус. мед. журн. 2009. № 24. C. 1586-1591.
14. Bekele S.,Yohannes T., Mohammed A.E. Dyslipidemia and associated factors among diabetic patients attending Durame General Hospital in Southern Nations, Nationalities, and People’s Region // Diabetes Metab. Syndr. Obes. 2017. Vol. 10. P. 265-271.
15. Воевода М.И., Ковалькова Н.А., Рагино Ю.И. и др. Распространенность метаболического синдрома у жителей Новосибирска в возрасте от 25 до 45 лет // Терапевт. архив. 2016. Т. 10. С. 51-56.
16. Мустафина С.В., Никитин Ю.П., Симонова Г.И., Щербакова Л.В. Распространенность дислипидемий при сахарном диабете в возрасте 46-69 лет в г. Новосибирске // Атеросклероз. 2014. Т. 10, № 4. С. 26-32.
Review
For citations:
Ovsyannikova A.K., Shcherbakova L.V., Mustafina S.V., Ragino Yu.I., Denisova D.V., Kuntsevich A.K., Rymar O.D. Lipid profile in young people with newly diagnosed type 2 diabetes mellitus. Ateroscleroz. 2018;14(3):39-44. (In Russ.) https://doi.org/10.15372/ATER20180306
Views:
177
Email this article 